Blood Weekly articles from July 2002

Blood Weekly archives from July 2002

Opioid receptor expressed by cord blood cells.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Some hematopoietic stem cells carry opioid receptors, researchers in Israel report. "Opioid receptor expression and function traditionally have been...

Peripheral blood grafts less likely to induce inflammatory response.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic stem cell grafts may be less likely to provoke dangerous inflammatory immune responses when they comprise peripheral blood cells, researchers in...

Doctors develop a new way to spot internal bleeding.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Internal bleeding is an invisible, insidious killer. By the time most doctors spot it, it's usually too late for the patient. But a new device that monitors the level of oxygen in the blood could give...

New test allows for quicker identification of defective gene.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - There are several complementation groups in Fanconi anemia. Researchers in Germany have developed a novel way to characterize these subtypes almost immediately...

New gene therapy tool successfully treats mice with hemophilia A.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Scientists at the University of North Carolina have successfully treated mice with hemophilia A using a new approach to gene therapy - RNA trans-splicing. The experimental procedure repairs a mutated...

Novel assay can measure long-term engraftment with low cell counts.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel assay could facilitate greater understanding of the process of hematopoietic stem cell engraftment, researchers say. "Of various types of xenograft...

Aranesp studies explore potential of new anemia treatment paradigms.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Clinical data from four Aranesp (darbepoetin alfa) studies presented at the 38th annual meeting of the American Society of Clinical Oncology (ASCO) suggest new potential dosing approaches for treating...

Abaxis taps Al Santa Ines as chief financial officer.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc. (ABAX) announced that it has appointed Al Santa Ines to the position of vice president of finance and chief financial officer, effective immediately. Mr. Santa Ines joined Abaxis in...

Kourion names Jurgen Peter CFO; Christian Van Den Bos VP, development, operations.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Kourion Therapeutics, a leader in cord blood-derived therapeutic stem cell products, announced that Jurgen Peter has joined the company as its chief financial officer and Christian van den Bos, PhD, has...

Nitric oxide joins oxygen and carbon dioxide as third key gas in human respiration.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Investigators from Duke University Medical Center and the Howard Hughes Medical Institute (HHMI) have demonstrated that red blood cells play a crucial and active role in responding to the oxygen needs...

Capabilities of the Autopure LS extended.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Gentra Systems introduced the extended capabilities of the Autopure LS at the annual ISBER meeting in Danvers, Massachusetts in May 2002. The Autopure LS is unique among automated nucleic acid...

ATRA helps maintain hemostasis.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - In addition to its anticancer effects, all-trans-retinoic acid (ATRA) can help breast cancer patients maintain hemostasis before surgery, researchers in Italy...

Filgrastim is beneficial after stem cell transplantation.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Spain say that filgrastim (granulocyte colony-stimulating factor, or G-CSF) treatment can help breast cancer patients recover from hematopoietic...

Protein complex found to regulate first step in human blood clotting.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Brown scientists have described a previously unknown but critical blood clotting role for Arp2/3, a complex of seven proteins found in animal and plant cells. Reporting in the June 15, 2002, issue...

Anemia complicates heart failure, should be new focus, doctor says.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Anemia appears to be an underappreciated contributor to problems associated with congestive heart failure (CHF), a University of North Carolina at Chapel Hill cardiologist says. That's important, he...

Baxter introduces The BAXJECT needleless transfer device.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Baxter BioScience announced the launch of the BAXJECT needleless transfer device (BAXJECT), a way to prepare hemophilia medication without the use of sharp needles or fear of accidental injury, at the...

Latest technological advance in hemophilia a therapy presented.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- The first recombinant Factor VIII therapy for hemophilia A prepared entirely without the use of human- or animal-derived additives was found to be bioequivalent to the current gold- standard recombinant...

Better tests may help detect congenital syphilis in newborns.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- A University of Texas (UT) Southwestern Medical Center at Dallas research team has developed two blood tests that quickly and reliably diagnose congenital syphilis in newborns. "This is the first...

Application for registering Stem Cell Preservation Technologies to be filed.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Daniel D. Richard, founder and CEO of Cryo-Cell International, Inc., (CCEL) announced that Stem Cell Preservation Technologies, Inc., (SCPT) will file a Registration Statement to the Securities and...

CRYO-CELL announces acquisition by affiliate, CRYO-CELL Europe.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Cryo-Cell International, Inc. (CCEL) announced that its affiliate, Cryo-Cell Europe, N.V., Zutphen, the Netherlands has completed the acquisition of MainGen GmbH from Asta Medica AG, a subsidiary of...

Aastrom applies to move to Nasdaq SmallCap market.
July 4, 2002... 2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc. (ASTM) submitted a request for approval from the Nasdaq Stock Market to transfer its listing from the National Market to the SmallCap Market. The change maintains Aastrom's...

Synthetic liposomes can act as platelet substitutes.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Encapsulated synthetic phospholipids can promote hemostasis in an experimental model, researchers in Spain report. "The possibility of developing synthetic...

Anticancer mechanisms of donor lymphocyte infusions elucidated.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Europe have shed new light on the beneficial effects of donor lymphocyte infusions for leukemia patients. "Donor lymphocyte infusions (DLI)...

New treatment paradigm means patients get better quicker.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Clinical data from five Aranesp (darbepoetin alfa) studies presented at the 38th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando,...

Brazilian study finds link between hepatitis C and non-Hodgkin lymphoma.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A link between hepatitis C virus (HCV) infection and non-Hodgkin lymphoma has been established by research investigators in Brazil. The epidemiological...

Protein discovered that keeps hemoglobin in balance.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- Hematology researchers at the Children's Hospital of Philadelphia have discovered a gene and its associated protein that may have major implications for red blood cell formation, specifically for...

Endothelial nitric oxide synthase dysregulation may add to stroke morbidity.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have shed new light on the factors underlying vascular morbidity after thromboembolic stroke. "Although vascular...

Approval granted for generic Benadryl injection.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners (APPX) announced it has received approval from the U.S. Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) of diphenhydramine...

Medicare coverage expanded to include home blood coagulation monitor.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- International Technidyne Corp. (ITC) said that the recent expansion of Medicare coverage to include home use of the company's anticoagulation therapy monitoring system will significantly expand the...

i-Stat picks new chief financial officer.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- i-Stat Corp. (STAT), a manufacturer of point-of-care diagnostic systems for blood analysis, has appointed Lorin Jeffry Randall as senior vice president of finance, chief financial officer, and...

Phenprocoumon superior to acenocoumarol.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Phenprocoumon is a superior alternative to acenocoumarol for long-term oral anticoagulant therapy (OAT), researchers in the Netherlands argue. Dr. Alain...

NIDDKD summarizes progress and future directions for management.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- Substantial advances in treatment for chronic hepatitis C and a decline in the number of new infections, were highlighted by a panel convened by the U.S. National Institutes of Health (NIH). ...

Monoclonal antibody improves patient response to therapy.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - A new treatment approach for acute myeloid leukemia (AML) that combines a monoclonal antibody with chemotherapy helps to improve patients' response to therapy...

Amgen to acquire filgrastim, pegfilgrastim in Europe.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- Roche and Amgen (AMGN) announced that Amgen has purchased from Roche the assets and business related to filgrastim and pegfilgrastim in the European Union, Switzerland, and Norway. Filgrastim and...

University of Kent scientists tackle blood diseases.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Kent have received grants totaling more than 160,000 British pounds to help the development of an National Health Service (NHS) antenatal and neonatal screening program...

Exercise response in women studied.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- A study showing that women with sickle cell anemia can safely perform maximal cardiopulmonary exercise if they are allowed to stop when the need arises has been published in the American Journal of...

Novel vitamin E analog may be effective for treatment.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Taiwan have identified a novel agent that shows promise for treatment of thrombosis. Dr. George Hsiao and colleagues working at Taipei...

Competition for blood donors heats up.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- Of the 14 million pints of blood donated each year, just 250 come from teenagers at Shawnee Mission North High School outside Kansas City. But in the intensely competitive business of blood banking,...

Poll: American people trust blood supply.
July 11, 2002... 2002 JUL 11 - (NewsRx.com & NewsRx.net) -- Americans have a growing confidence in the blood supply and generally feel hospitals can provide blood when needed, even though most people don't donate blood, says an Associated Press poll. ...

STI571 reduces proliferative advantage of malignant progenitor cells.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have shed new light on the mechanisms of a powerful and novel treatment for leukemia. "Imatinib mesylate (STI571) is a...

Serum ferritin may not be accurate iron proxy for sickle cell patients.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Serum ferritin may be overrated as a proxy for iron levels in frequently transfused sickle cell anemia and other patients, researchers in the United States...

Protective genetic factors identified.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Europe have identified several genetic risk factors for the development of acute lymphocytic leukemia (ALL). "We...

STI-571 emerges as new standard of care for early and advanced CML.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Janis Kelly, senior medical writer - Imatinib (STI-571, Gleevec) is so much better than interferon for newly diagnosed chronic myeloid leukemia (CML) that it should now be considered the standard of...

Conjugated CD20 vaccine elicits specific, polyclonal immune response in mice.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The CD20 antigen, expressed only on B lineage cells before differentiation into plasma cells, produced a strong, specific, polyclonal immune response...

Ritonavir can reduce Kaposi sarcoma risk.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The antiretroviral agent ritonavir may help prevent the development of Kaposi sarcoma (KS) in HIV patients, researchers in the United States report. ...

Product R approved in Israel for phase I study.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that its immunomodulator-type drug, Product R, has been approved by the supreme medical ethics committee (Helsinki Committee) of the Ministry of Health in...

Blood tests may help determine which older women are at higher risk for disability and death.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Older women with abnormal levels of two substances - a growth hormone and a biological marker tied to inflammation - may be at higher risk for becoming disabled or dying, according to the results of a...

INGN 251 shows early promise in treating vascular proliferative disorders and melanoma.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Introgen Therapeutics, Inc., (INGN) researchers and collaborators at the Texas Heart Institute, The University of Texas-Houston and The University of Texas M.D. Anderson Cancer Center, presented...

Nanogen expands genetic content patent portfolio.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Nanogen, Inc., (NGEN) announced the issuance of U.S. Patent No. 6,355,425 (the '425 patent) entitled "Mutations Associated with Iron Disorders" relating to methods for the detection of certain...

Viral infections may not underlie transient pediatric erythroblastopenia.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Sweden have shed new light on the pathogenesis of a severe but temporary form of pediatric anemia. "It has been proposed that human...

WT1 useful as pediatric disease marker.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The WT1 gene is useful for determining disease progression in pediatric leukemia patients, researchers in the United States report. "WT1 encodes a...

Gene test predicts survival.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Cancer researchers have devised a genetic test that can accurately predict the survival chances of patients with some aggressive forms of lymphoma. The test yielded a genetically based survival...

Fathering cancer: Is the next generation paying the price for Sellafield after all?
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Working at the Sellafield nuclear plant in Cumbria, U.K., may have been harmful after all, according to a study published in the International Journal of Cancer and reviewed in New Scientist...

Hematopoietic stem cells may aid recovery.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Bone marrow-derived hematopoietic stem cells may be useful for improving poststroke recovery, researchers in the United States report. "After an ischemic...

Protein discovered that keeps hemoglobin in balance.
July 18, 2002... 2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Hematology researchers at The Children's Hospital of Philadelphia have discovered a gene and its associated protein that may have major implications for red blood cell formation - specifically for...

Platelet factors can modulate risk.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Platelets may have a significant role in the development of atherosclerosis, researchers report. "The influence of platelets on the cellular metabolism of...

Exogenous melatonin protects peripheral blood cells.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Melatonin could be useful for protecting peripheral blood cells from the damaging effects of radiation therapy, researchers in Turkey report. "Melatonin...

Color ultrasound-guided biopsy useful for diagnosing post-transplant liver damage.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Liver biopsy guided by color ultrasound is highly useful for finding and characterizing liver dysfunction in patients who undergo bone marrow transplantation,...

Substantial increase in death rate after bypass surgery for people with anemia.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Anemic patients undergoing coronary artery bypass surgery could have up to a five-fold increased risk of death in the days after surgery compared with patients who have normal haemoglobin...

Antibiotic treatment can increase blood dyscrasia risk.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Antibiotic treatment may increase the risk of pathological blood conditions, researchers in Spain warn. "Blood dyscrasias, although rare, can be fatal,"...

CYP26 mediates rapid ATRA tolerance.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States may have identified the reason for the rapid development of tolerance to all-trans-retinoic acid (ATRA). This agent...

Interleukin-7 increases risk of naive T-cell infection.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The immunomodulatory cytokine interleukin (IL)-7 potentiates HIV infection of some cells thought to be safe from the virus, researchers in the United States...

Abaxis shipped blood chemistry analyzers to U.S. military.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced it had received an order from the U.S. Military for 24 of its Piccolo Blood Chemistry...

Cord blood cells improve rats' neurological recovery, new study finds.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Intravenous injections of cells from human umbilical cord blood improved the neurological and motor function of rats recovering from severe traumatic brain injury, researchers at Henry Ford Health...

Antivascular agents effective in combination with other anticancer drugs.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Drugs which target blood vessels providing tumors with needed nourishment work well in combination with conventional chemotherapy agents, researchers in the...

MedMira closes $3.25 million private placement.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- MedMira, Inc., announced that it has completed a private placement financing originally announced in a press release dated May 14, 2002. As announced, the private placement involved the issuance of...

Immunomedics announces additional interim results of epratuzumab combination in treating non-Hodgkin lymphoma.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced at the 38th annual meeting of the American Society of Clinical Oncology in Orlando, Florida, that interim results of the phase II clinical trial testing the cancer...

Patent issued for culture and encapsulation of pancreatic islet cells for transplantation.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- MicroIslet, Inc., (MIIS) announced that the United States Patent Office has granted patent number 6,365,385, which is licensed exclusively to the company under its license agreement with Duke...

ABO mismatch may be beneficial for bone marrow recipients.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Divergent donor-recipient blood types can improve the anticancer effects of allogeneic bone marrow transplantation (BMT), researchers say. Dr. Jayesh...

Promising new therapies in the works.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Fresh from successes in the development of the cancer-fighting drug Gleevec, researchers are now setting their sights on a form of acute myelogenous leukemia (AML) that carries a bleak prognosis. They...

Chemoembolization offers survival benefit.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- People with liver cancer that cannot be treated with surgical resection or transplantation could have an increased 2-year survival if they are given chemoembolization - a procedure in which blood...

Hematological disorders represent significant growth potential for pharmaceutical industry.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Decision Resources announced the availability of a new DR Report entitled "The Hematology Market: An Overview of Marketed and Emerging Therapies." The report reviews various blood disorders and the...

aaiPharma announces issuance of cilostazol patent.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- aaiPharma, Inc., (AAII) announced the issuance of a patent filed by the company relating to cilostazol. The patent, entitled "Polymorphic forms of...

Website for children launched.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- The first phase of an innovative website designed for children with sickle cell anemia was recently launched, making it the first website of its kind specifically designed for youngsters suffering from...

Novel assay can determine post-transplant cytomegalovirus susceptibility.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Germany have developed a novel assay for measuring patient susceptibility to cytomegalovirus infection or reactivation after stem cell...

Procalcitonin has limited utility for predicting infectious morbidity.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Despite widespread attention, the hormone precursor procalcitonin is not superior to standard diagnostic markers of infection following stem cell...

Blood stem cell transplantation holds hope for autoimmune diseases.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- For patients with severe autoimmune diseases, blood stem cell transplantation may be promising therapy option. This process involves an infusion of healthy blood cells to replace the body's own...

New approach to post-transplant lymphoma shows promise.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Scientists may be making significant headway in treating one of the most difficult and often fatal complications of organ transplant, PTLD, or post-transplant lymphoproliferative disorder. PTLD is...

Potential of regenerative medicine explored.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Clinical and basic science research findings of more than a dozen studies were presented by researchers from the University of Pittsburgh's McGowan Institute for Regenerative Medicine at the 48th...

Researchers report first evidence that nuclear transplantation can eliminate tissue rejection.
July 25, 2002... 2002 JUL 25 - (NewsRx.com & NewsRx.net) -- Advanced Cell Technology, Inc., (ACT) reported that nuclear transplantation can be used to generate functional immune-compatible tissues. The research, which will appear as the July 2002 cover story...